line

Innovative Science
Affordable Medicine

We are growing every moment to be the best in global competition

WELLMARKERBIO

Wellmarker Bio Co., Ltd. is the first spin off company from Asan Medical Center
developing patient-oriented anticancer drug based on precision medicine.

Wellmarker Bio Co., Ltd is developing new anticancer drug based on a predictive biomarker.
Our company aims to provide optimized treatments to patients with medical
unmet needs through innovative R&D.

Learn More

Our Technology

What is a Predictive Biomarker?
line

A predictive biomarker shows information about
our body. It helps to evaluate how well a treatment is likely
to work in a particular patient.

To develop predictive biomarker, various
technologies such as genomics,transcriptomics,
proteomics, and metabolomics based on
blood/tissue samples and clinical information
from patients are required.

What is an Optimal pathway?
line

WMBIO has a unique business model called
‘Optimal Pathway’. We develop predictive
biomarker as well as anti-cancer drugs based on
patient-derived samples.

By using predictive biomarker, we can provide
cost-effective, personalized treatment that could
increase the success rate of developing new
drugs.

COMPANY

Address

(05855) 7F, 155
Songpadae-ro Songpa-gu, Seoul, Korea

CONTACT US

Tel.

+82-2-6952-1631

Fax.

+82-2-6952-1648

E-mail.

bjy6820@wmbio.co